PGL prospa group limited.

This is a great one to short, with so much downside. There are...

  1. 580 Posts.
    This is a great one to short, with so much downside. There are no near-term price catalysts, and a valuation model points to $3 being optimistic for this fledgling biotech. I can't see current levels as anything other than wild speculation.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.